NDAINTRAVENOUSSOLUTION
Approved
Jan 2020
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
11
Data completeness
3/8 — Basic
Drug data last refreshed 3d ago
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (11)
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
Started May 2025
1,900 enrolled
Chronic Heart FailureIron Deficiencies
Monoferric for Prenatal Iron Deficiency
Started Jan 2024
80 enrolled
Obstetric Labor Complications
The Effects of Ferric Derisomaltose on Postoperative Anemia in Spinal Deformity Surgery
Started Aug 2023
120 enrolled
Perioperative AnemiaSurgerySpinal Deformity+1 more
Multi-center Trial of Ferric Derisomaltose in Children 0 to <18 Years of Age With Iron Deficiency Anemia
Started Nov 2022
200 enrolled
Iron Deficiency, Anaemia in Children
Preoperative Monoferric for Abdominal Surgery
Started Nov 2022
32 enrolled
AnemiaSurgery
Worked on MONOFERRIC at Pharmacosmos? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.